Multipurpose prevention technologies for sexual and reproductive health: Establishing a novel, collaborative way for scientific agenda development
METHODS: To foster cross-disciplinary collaborations and advance the scientific agenda, CAMI.IMPT has identified three priority working groups: the Scientific Agenda Working Group (SAWG); Communications and Advocacy Working Group (CAWG); and Acceptability and Access Working Group (AAWG).
RESULTS: The SAWG considered the alignment of technologically feasible products with ideal' products. In addition, Target Product Profiles (TPPs) define key attributes for MPT products in regions of the world with high unmet need. This collaborative effort informs product developers and donors in pipeline decisions. Simultaneously, the CAWG worked with regional representatives to develop key messages for MPTs in India. In December 2012, CAMI.IMPT helped convene a symposium on MPTs in India to identify research priorities and define an agenda for research relevant to India.
CONCLUSIONS: A collaborative multidisciplinary approach to advancing the scientific agenda for MPTs helps ensure that early in product development, developers listen to end-users and providers as women's needs greatly vary. By working together, CAMI.IMPT members can better advance the development and introduction of MPTs.
Learning Areas:Advocacy for health and health education
Protection of the public in relation to communicable diseases including prevention or control
Public health or related research
Social and behavioral sciences
Describe a collaborative and multidisciplinary approach to inform the scientific agenda for early product development of multipurpose prevention technologies (MPTs) for sexual and reproductive health.
Keyword(s): Reproductive Health, Reproductive Health Research
Qualified on the content I am responsible for because: Dr. Holt directs the Coalition Advancing Multipurpose Innovations (CAMI), and is also a Principle Investigator (PI) with the Public Health Institute, which houses CAMI. Dr. Holt has nearly 20 years of experience working in reproductive health and HIV/STI prevention in the U.S. and internationally, including multi-level analyses, social determinants of health, microbicide acceptability studies, and market research. She received her MPH in Maternal and Child Health and PhD in Epidemiology from UC Berkeley.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.